
|Articles|May 9, 2004
Prostate cancer treatment outcomes, robotic techniques grabbing headlinesat this year's AUA
Over the next 5 days, urologists can expect to hear a great deal aboutprostate cancer treatment outcomes, robotic and minimally invasive surgicaltechniques, pelvic pain in both men and women, the obesity epidemic andits connection to prostate cancer, and advances in erectile dysfunctiontherapy. These are among the key areas of scientific research grabbing headlinesat this year's AUA annual meeting, said J. Brantley Thrasher, MD, chairof AUA's Public Media Committee.Dr. Thrasher briefed a small group of journalists yesterday on theseand other significant topics that make up part of the nearly 2,000 researchpapers being presented here.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5










